Medicare Enrolled
Dr. Yunhui Hsiang, M.D., PHD
Medical Oncology · Ft Walton Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsiang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsiang? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hsiang
Dr. Yunhui Hsiang is a medical oncology in Ft Walton Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Hsiang performed 338,842 Medicare services across 5,097 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hsiang received a total of $16,010 from 86 pharmaceutical and/or device companies across 1007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hsiang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 4% volume in FL$ $16,010 industry payments
Medicare Practice Summary
Medicare Utilization ↗338,842
Medicare services
Top 4% in FL for medical oncology
5,097
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,834 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 88,500 | $1 | $2 |
| Pembrolizumab injection (Keytruda) | 39,600 | $42 | $71 |
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 35,280 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 32,760 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 31,740 | $18 | $37 |
| Iron infusion (Feraheme) | 17,850 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) | 13,650 | $0 | $1 |
| Injection, rituximab 10 mg and hyaluronidase | 11,340 | $29 | $50 |
| Injection, bortezomib, 0.1 mg | 9,990 | $4 | $27 |
| Paclitaxel chemotherapy injection | 8,926 | $0 | $1 |
| Dexamethasone injection (steroid) | 8,478 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia | 5,760 | $6 | $12 |
| Anti-nausea injection (Aloxi/palonosetron) | 5,567 | $1 | $7 |
| Epoetin alfa injection (Retacrit) for anemia | 4,740 | $6 | $11 |
| Complete blood count (CBC) with differential | 3,805 | $8 | $17 |
| Iron infusion (Monoferric) | 2,600 | $17 | $31 |
| Blood draw (venipuncture) | 2,110 | $8 | $11 |
| Injection, rituximab, 10 mg | 1,960 | $64 | $108 |
| Office visit, established patient (20-29 min) | 1,649 | $65 | $125 |
| Office visit, established patient (30-39 min) | 1,332 | $98 | $183 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 1,038 | $17 | $32 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 1,025 | $3 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 995 | $98 | $230 |
| Injection, granisetron hydrochloride, 100 mcg | 960 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 910 | $22 | $57 |
| Drug injection, under skin or into muscle | 813 | $11 | $30 |
| Injection, cetirizine hydrochloride, 0.5 mg | 780 | $12 | $20 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 688 | $55 | $105 |
| Injection of additional new drug or substance into vein | 673 | $12 | $37 |
| Injection, carboplatin, 50 mg | 574 | $2 | $10 |
| Office visit, established patient, complex (40-54 min) | 417 | $140 | $256 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 252 | $49 | $107 |
| Administration of additional new drug or substance into vein, 1 hour or less | 221 | $50 | $114 |
| Administration of chemotherapy into vein, each additional hour | 211 | $20 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 198 | $133 | $245 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 192 | $26 | $61 |
| Hospital follow-up visit, moderate complexity | 166 | $64 | $115 |
| Irrigation of implanted venous access drug delivery device | 147 | $16 | $41 |
| New patient office visit, complex (60-74 min) | 139 | $172 | $315 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 110 | $1 | $4 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 104 | $1 | $5 |
| Drawing of blood for a medical problem | 92 | $72 | $135 |
| Infusion into a vein for hydration, each additional hour | 76 | $10 | $27 |
| Administration of additional new drug or substance into vein using push technique | 71 | $39 | $103 |
| Infusion into a vein for hydration, 31-60 minutes | 68 | $25 | $88 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 67 | $15 | $31 |
| Initial hospital admission, high complexity | 64 | $139 | $252 |
| Injection of drug or substance into vein | 40 | $29 | $82 |
| Stool analysis for blood to screen for colon tumors | 35 | $4 | $7 |
| Hospital follow-up visit, high complexity | 35 | $96 | $175 |
| Infusion, normal saline solution , 1000 cc | 29 | $2 | $5 |
| Office visit, established patient (10-19 min) | 15 | $45 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.6% high complexity
64.0% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,010
Total received (2018-2024)
Avg $2,287/year across 7 years
Top 33% in FL for medical oncology
86
Companies
1,007
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,164 (94.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$652 (4.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$194 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,525
2023$3,536
2022$2,575
2021$2,239
2020$1,226
2019$1,761
2018$1,149
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,792
Amgen Inc.
$1,363
Celgene Corporation
$889
Janssen Biotech, Inc.
$840
Regeneron Healthcare Solutions, Inc.
$713
AstraZeneca Pharmaceuticals LP
$692
Astellas Pharma US Inc
$639
Lilly USA, LLC
$585
PFIZER INC.
$509
GENZYME CORPORATION
$465
Merck Sharp & Dohme LLC
$426
E.R. Squibb & Sons, L.L.C.
$376
Daiichi Sankyo Inc.
$373
Takeda Pharmaceuticals U.S.A., Inc.
$341
Exelixis Inc.
$330
Genentech USA, Inc.
$312
Eisai Inc.
$307
Gilead Sciences, Inc.
$300
GlaxoSmithKline, LLC.
$274
Octapharma USA, Inc.
$235
Incyte Corporation
$221
Ipsen Biopharmaceuticals, Inc
$205
Merck Sharp & Dohme Corporation
$197
Epizyme, Inc.,
$189
Puma Biotechnology, Inc.
$177
JAZZ PHARMACEUTICALS INC.
$156
Blueprint Medicines Corporation
$154
Seagen Inc.
$148
ARRAY BIOPHARMA INC
$140
ABBVIE INC.
$133
EMD Serono, Inc.
$127
Deciphera Pharmaceuticals Inc.
$123
SANOFI-AVENTIS U.S. LLC
$112
Heron Therapeutics, Inc.
$106
Pharmacosmos Therapeutics Inc.
$97
Sumitomo Pharma America, Inc.
$94
Foundation Medicine, Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$89
PharmaEssentia USA Corporation
$86
Spectrum Pharmaceuticals Inc.
$80
Mirati Therapeutics, Inc.
$79
Myovant Sciences Inc.
$77
Alexion Pharmaceuticals, Inc.
$70
TerSera Therapeutics LLC
$69
BeiGene USA, Inc.
$62
Bayer HealthCare Pharmaceuticals Inc.
$60
Karyopharm Therapeutics Inc.
$59
AVEO Pharmaceuticals, Inc.
$58
Clovis Oncology, Inc.
$54
EISAI INC.
$54
Coherus Biosciences Inc.
$50
TAIHO ONCOLOGY, INC.
$47
Adaptive Biotechnologies Corporation
$46
Pharmacyclics LLC, An AbbVie Company
$44
Shire North American Group Inc
$36
ImmunoGen, Inc.
$33
Taiho Oncology, Inc.
$32
AbbVie Inc.
$31
Janssen Scientific Affairs, LLC
$30
Kite Pharma, Inc.
$27
Emmaus Medical, Inc.
$27
Alnylam Pharmaceuticals Inc.
$23
AMAG Pharmaceuticals, Inc.
$23
AbbVie, Inc.
$23
SpringWorks Therapeutics, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$21
Biocompatibles, Inc.
$20
SOBI, INC
$19
TG Therapeutics, Inc.
$19
Sobi, Inc
$18
G1 Therapeutics, Inc.
$16
Genmab U.S., Inc.
$15
Fennec Pharmaceuticals, Inc.
$15
Verastem, Inc.
$15
Acceleron Pharma, Inc.
$15
Acrotech Biopharma Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
MorphoSys, US Inc.
$13
TESARO, Inc.
$12
EUSA Pharma (US) LLC
$12
Lexicon Pharmaceuticals, Inc.
$12
PUMA BIOTECHNOLOGY, INC.
$12
Sirtex Medical Inc
$12
Acrotech Biopharma LLC
$11
INSYS Therapeutics Inc
$11
Top 3 companies account for 25.3% of total payments
Associated products mentioned in payments ›
ADYNOVATE · AFINITOR · ALIMTA · ALTUVIIIO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Elahere · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUBSYS · SUSTOL · SYLVANT · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · THERASPHERE - BIO · TIVDAK · TUKYSA · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VPRIV · Vectibix · Venclexta · Vitrakvi · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
2
Per 100K population
0.9
County median income
$79,097
Nearest hospital
HCA FLORIDA FORT WALTON-DESTIN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hsiang is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hsiang experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Hsiang performed 88,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsiang receive payments from pharmaceutical companies?
Yes. Dr. Hsiang received a total of $16,010 from 86 companies across 1,007 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsiang's costs compare to other medical oncologys in Ft Walton Beach?
Dr. Hsiang's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsiang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Ft Walton Beach
Browse medical oncologys in Ft Walton Beach ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology